Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection.

Joshi, Tejas; Rana, Abbas; Vierling, John M; Kanwal, Fasiha; Goss, John A; Cholankeril, George

Joshi, Tejas; Rana, Abbas; Vierling, John M; Kanwal, Fasiha; Goss, John A; Cholankeril, George.

Joshi T; Liver Center, Division of Abdominal Transplantation, Michael E. DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX.
Rana A; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.
Vierling JM; Liver Center, Division of Abdominal Transplantation, Michael E. DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX.
Kanwal F; Liver Center, Division of Abdominal Transplantation, Michael E. DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX.
Goss JA; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.
Cholankeril G; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.

Liver Transpl ; 28(1): 127-130, 2022 01.

Article in English | MEDLINE | ID: covidwho-1432449

Subject(s)

COVID-19; Liver Transplantation; Drug Monitoring; Humans; Immunosuppressive Agents/adverse effects; Liver Transplantation/adverse effects; SARS-CoV-2; Tacrolimus/adverse effects; Transplant Recipients

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Transplantation / COVID-19 Limits: Humans Language: English Journal: Liver Transpl Journal subject: Gastroenterology / Transplantation Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google